188 related articles for article (PubMed ID: 32544573)
1. Adjuvant Nodal Radiation Therapy for Melanoma in the Era of Immunotherapy.
Mitra D; Bishop A; Guadagnolo BA
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):164-169. PubMed ID: 32544573
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
Bhave P; Hong A; Lo SN; Johnson R; Mangana J; Johnson DB; Dulgar O; Eroglu Z; Yeoh HL; Haydon A; Lodde GC; Livingstone E; Khattak A; Kähler K; Hausschild A; McArthur GA; Menzies AM; Long G; Wang W; Carlino MS
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36889810
[TBL] [Abstract][Full Text] [Related]
3. [Sentinel node biopsy and lymph node dissection in the era of new systemic therapies for malignant melanoma].
Ulmer A; Kofler L
Hautarzt; 2019 Nov; 70(11):864-869. PubMed ID: 31605168
[TBL] [Abstract][Full Text] [Related]
4. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
McKean MA; Amaria RN
Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift.
Hieken TJ; Kreidieh F; Aedo-Lopez V; Block MS; McArthur GA; Amaria RN
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e390614. PubMed ID: 37116111
[TBL] [Abstract][Full Text] [Related]
8. The extent of surgery for stage III melanoma: how much is appropriate?
Franke V; van Akkooi ACJ
Lancet Oncol; 2019 Mar; 20(3):e167-e174. PubMed ID: 30842060
[TBL] [Abstract][Full Text] [Related]
9. The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.
Danish HH; Patel KR; Switchenko JM; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
Melanoma Res; 2016 Dec; 26(6):595-603. PubMed ID: 27575390
[TBL] [Abstract][Full Text] [Related]
10. The Role and Necessity of Sentinel Lymph Node Biopsy for Invasive Melanoma.
Nakamura Y
Front Med (Lausanne); 2019; 6():231. PubMed ID: 31696119
[TBL] [Abstract][Full Text] [Related]
11. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.
Burmeister BH; Mark Smithers B; Burmeister E; Baumann K; Davis S; Krawitz H; Johnson C; Spry N;
Radiother Oncol; 2006 Nov; 81(2):136-42. PubMed ID: 17064803
[TBL] [Abstract][Full Text] [Related]
12. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
Ballo MT; Garden AS; Myers JN; Lee JE; Diaz EM; Sturgis EM; Morrison WH; Gershenwald JE; Ross MI; Weber RS; Ang KK
Head Neck; 2005 Aug; 27(8):718-21. PubMed ID: 15952196
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series.
Finger PT; Pavlick AC
J Immunother Cancer; 2019 Mar; 7(1):83. PubMed ID: 30909967
[TBL] [Abstract][Full Text] [Related]
14. Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma -- a retrospective single centre study.
Gyorki DE; Ainslie J; Joon ML; Henderson MA; Millward M; McArthur GA
Melanoma Res; 2004 Jun; 14(3):223-30. PubMed ID: 15179193
[TBL] [Abstract][Full Text] [Related]
15. The adjuvant treatment revolution for high-risk melanoma patients.
Spagnolo F; Boutros A; Tanda E; Queirolo P
Semin Cancer Biol; 2019 Dec; 59():283-289. PubMed ID: 31445219
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality therapy for patients with regional nodal metastases from melanoma.
Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma.
Guadagnolo BA; Zagars GK
Lancet Oncol; 2009 Apr; 10(4):409-16. PubMed ID: 19341972
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
[TBL] [Abstract][Full Text] [Related]
20. [Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Orion C; Dinulescu M; Dalac-Rat S; Giacchero D; Jouary T; Lebbé C; Leccia MT; Maubec E; Meyer N; Mortier L; Dupuy A;
Ann Dermatol Venereol; 2020 Jan; 147(1):9-17. PubMed ID: 31761496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
